pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
verekitug
Nasal Polyps (Nasal Polyposis)
$UPBUpstream Bio, Inc.
0 catalysts
Marketed
vericiguat
Verquvo (vericiguat)
Systolic Heart Failure (HFrEF)
Merck Sharp & Dohme LLC
0 catalysts
Marketed
vestronidase alfa
MepseVII (vestronidase alfa-vjbk)
Mucopolysaccharidosis VII (MPS VII) (Sly Syndrome )
$RAREUltragenyx Pharmaceutical Inc.
0 catalysts
← prev
page 268 of 271
next →
131
Pain89
Neurology1
Phase 3
vezocolmitide hydrochloride
Keratoconjunctivitis Sicca (Dry Eye)
Stuart Therapeutics Inc
0 catalysts
Marketed
vibegron
Gemtesa (vibegron)
Overactive Bladder
Sumitomo Pharma America Inc
0 catalysts
Phase 3
vicadrostat
Diastolic Heart Failure (HFpEF)
Boehringer Ingelheim International GmbH
0 catalysts
Phase 2
vididencel
vididencel [INN]
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Mendus AB
0 catalysts
Phase 3
vidofludimus calcium
Relapsing Remitting Multiple Sclerosis (RRMS)
$IMUXIMMUNIC, INC.
0 catalysts
Phase 2
vilastobart
Cervical Cancer
$XLOXilio Therapeutics, Inc.
0 catalysts
Marketed
vilazodone hydrochloride
Viibryd (vilazodone hydrochloride)
Major Depressive Disorder
Allergan Sales LLC
0 catalysts
Phase 2
vilobelimab
Gohibic (vilobelimab)
Acute Respiratory Distress Syndrome
Complement C5
InflaRx NV
0 catalysts
Marketed
viloxazine hydrochloride ER
Qelbree (viloxazine hydrochloride)
Attention Deficit Hyperactivity Disorder (ADHD)
$SUPNSUPERNUS PHARMACEUTICALS, INC.
0 catalysts
Marketed
viltolarsen
Viltepso (viltolarsen)
Duchenne Muscular Dystrophy
NS Pharma Inc
0 catalysts
Marketed
vimseltinib
Romvimza (vimseltinib)
Graft Versus Host Disease (GVHD)
Ono Pharmaceutical Co Ltd
0 catalysts
Marketed
vinblastine sulfate
Vinblastine Sulfate (vinblastine sulfate)
Letterer-Siwe Disease (Multifocal and Multisystemic (Disseminated) Langerhans…
Fresenius Kabi USA LLC
0 catalysts
Phase 2
vinorelbine tartrate
Vinorelbine Tartrate (vinorelbine tartrate)
Soft Tissue Sarcoma
Tubulin
Taiwan Liposome Co Ltd
0 catalysts
Phase 2
visepegenatide
visepegenatide [INN]
Type 2 Diabetes
PegBio Co Ltd
0 catalysts
Marketed
vismodegib
Erivedge (vismodegib)
Basal Cell Carcinoma (Basal Cell Epithelioma)
Genentech Inc
0 catalysts
Phase 1
vispacabtagene regedleucel
B-Cell Non-Hodgkin Lymphoma
$CRBUCaribou Biosciences, Inc.
0 catalysts
Phase 2
visugromab
Metastatic Hepatocellular Carcinoma (HCC)
Catalym GmbH
0 catalysts
Preclinical
vitamin A palmitate
Bronchopulmonary Dysplasia
Advent Therapeutics Inc
0 catalysts
Phase 1
vobramitamab tavatecan
vobramitamab tavatecan[INN]
Bladder Cancer
$MGNXMACROGENICS INC
0 catalysts
Phase 2
vocacapsaicin hydrochloride
Post-Operative Pain
Concentric Analgesics Inc
0 catalysts
Phase 2
vodobatinib
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Tyrosine-protein kinase ABL1Bcr/Abl fusion protein
Sun Pharma Advanced Research Company Ltd
0 catalysts
Phase 2
volagidemab
Type 1 Diabetes (Juvenile Diabetes)
Glucagon receptor
Remd Biotherapeutics Inc
0 catalysts
Phase 2
volixibat potassium
Pruritus
$MIRMMirum Pharmaceuticals, Inc.
0 catalysts
Marketed
von willebrand factor (recombinant)
Vonvendi (von willebrand factor (recombinant))
Von Willebrand Disease (vWD)
Baxalta Inc
0 catalysts
Phase 2
vonafexor
vonafexor [INN]
Alport Syndrome
Enyo Pharma SA
0 catalysts
Phase 3
vonaprument
Geographic Atrophy
$ANNXAnnexon, Inc.
0 catalysts
Phase 2
vopimetostat
vopimetostat [INN]
Bladder Cancer
$TNGXTango Therapeutics, Inc.
0 catalysts